CD69 and COVID-19: Unsupervised analysis of MAIT cell flow cytometry phenotypes in all Atlas cohort patients and controls (n = 38) revealed a pattern of enhanced CD69 expression and diminished CXCR3 expression in both AM and AS COVID-19 patients (Fig. 2, A and B).